Cover |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Document Information [Line Items] | |
| Document Type | POS AM |
| Amendment Flag | true |
| Entity Registrant Name | Adaptin Bio, Inc. |
| Entity Central Index Key | 0001938571 |
| Entity Incorporation, State or Country Code | DE |
| Entity Filer Category | Non-accelerated Filer |
| Entity Small Business | true |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
| Amendment Description | Adaptin Bio, Inc. (the “Company,” “we,” “us,” or “our”) previously filed a registration statement with the Securities and Exchange Commission (the “SEC”) on Form S-1 (Registration No. 333-287338), as amended, which was declared effective by the SEC on August 4, 2025 (the “Registration Statement”).The Company is filing this Amendment to update the contents of the prospectus contained in the Registration Statement pursuant to Section 10(a)(3) of the Securities Act in respect of the continuous offering pursuant to Rule 415 of the shares of common stock described above. |